Alumis (ALMS) Capital Expenditures (2023 - 2025)
Alumis' (ALMS) quarterly Capital Expenditures came in at $462000.0 in Q4 2025, up 26.23% year-over-year from $366000.0 in Q4 2024, and down 86.21% quarter-over-quarter from $3.4 million in Q3 2025.
Powered by 
Analysis
Alumis (ALMS) Capital Expenditures (2023 - 2025) Analysis & Trends
Alumis (ALMS) has reported Capital Expenditures for 3 consecutive years, with $462000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Capital Expenditures rose 26.23% year-over-year to $462000.0 in Q4 2025; TTM through Dec 2025 was $5.5 million, a 219.57% increase from a year earlier, with the FY2025 full-year figure at $5.5 million, up 219.57% from the prior year.
- Capital Expenditures was $462000.0 for Q4 2025 at Alumis, down from $3.4 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $3.4 million in Q3 2025 and troughed at $38000.0 in Q1 2025.
- A 3-year average of $1.1 million and a median of $620500.0 in 2024 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 330.04% in 2025, down 75.48% in 2025.
- Over 3 years, Capital Expenditures stood at $1.2 million in 2023, then tumbled by 69.75% to $366000.0 in 2024, then advanced by 26.23% to $462000.0 in 2025.
- The last three Capital Expenditures figures came in at $462000.0 (Q4 2025), $3.4 million (Q3 2025), and $1.7 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 513.00 Mn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 140.00 Mn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 112.20 Mn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 240.20 Mn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 37.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 40.90 Mn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | -1.87 Mn |
| 10 | Alumis | 966.94 Mn | 464.65 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 462,000.00 |
| Sep 30, 2025 | 3.35 Mn |
| Jun 30, 2025 | 1.69 Mn |
| Mar 31, 2025 | 38,000.00 |
| Dec 31, 2024 | 366,000.00 |
| Sep 30, 2024 | 779,000.00 |
| Jun 30, 2024 | 432,000.00 |
| Mar 31, 2024 | 155,000.00 |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 2.17 Mn |
API Access
Alumis Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ALMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ALMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ALMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();